Lately, as a health coach working in this space, Ive been feeling a growing frustration about how these medications are sometimes being utilizedand more importantly, how the opportunity they create is often being missed
Saman Rahmanian congratulations Oral GLP-1 therapy that demonstrates efficacy comparable to injectable versions is rare in obesity care-this marks a shift from biologic-dominant treatment to pill-based options, lowering treatment burden for patients
According to FAIR Healths 2025 analysis of more than 51 billion commercial insurance claims, the share of adults prescribed a GLP-1 medication increased from 0.9% in 2019 to 4% in 2024
Known Adverse Reactions: Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps, diarrhea) have been reported
How should I adjust my semaglutide injection schedule when crossing time zones
do well with one treatment of Skin Classic